NeoMatrix Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- NeoMatrix Therapeutics's estimated annual revenue is currently $1.1M per year.
- NeoMatrix Therapeutics's estimated revenue per employee is $155,000
Employee Data
- NeoMatrix Therapeutics has 7 Employees.
- NeoMatrix Therapeutics grew their employee count by 0% last year.
NeoMatrix Therapeutics's People
| Name | Title | Email/Phone |
|---|
NeoMatrix Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is NeoMatrix Therapeutics?
NeoMatrix Therapeutics is a clinical-stage company dedicated to developing novel, bioactive peptides that prevent injury progression and thereby rescue tissue and speed healing. Our lead candidates focus on the treatment of severe burns and have the potential to significantly improve the quality of life and clinical outcomes of burn patients by limiting injury progression following the initial burn. This shortens healing time and reduces scarring. Continuing tissue destruction following an initial injury is a problematic phenomenon that occurs in many types of conditions, giving our novel peptides the potential to be used in multiple settings other than burns.
keywords:N/A
N/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Stony Brook University
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $42.9M | 269 | 5% | N/A |
#2 | $2202.2M | 5826 | 9% | N/A |
#3 | $3881.6M | 15403 | N/A | N/A |